Using AI to help track taking your mouth medication
Part of Mental health clinical trials.
This trial tests whether an artificial intelligence tool can measure how well people take their prescribed oral antipsychotic medicines. You may be able to take part if you are already in a community support program and you’ve been prescribed an oral antipsychotic.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are enrolled in a CSC program
- You have been prescribed an antipsychotic pill you take by mouth
- No special other exclusions are listed
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a smartphone-guided jaw muscle training program for people with schizophrenia. It aims to improve chewing function and related health, and uses a device called IOPI to measure your jaw strength.
This study uses an artificial intelligence (AI) system on your smartphone to see how your Parkinson's disease progresses and how you respond to medications. The goal is to help doctors better personalize your care.
This trial tests whether a smartphone app that uses artificial intelligence (AI) can help you quit smoking by looking at how it affects your dental health. If you smoke at least 5 cigarettes a day and want to quit, you may be able to join.
This study tests if a smartphone app can help improve motivation and thinking skills in people with psychotic disorders like schizophrenia. It is designed for those who own a smartphone and are having trouble with memory or focus.
This study uses speech recordings from a smartphone app to see if changes in the way you talk can predict when someone might have a relapse of psychosis. It is for people who are currently stable or for healthy volunteers to compare.
This trial tests a smartphone app designed to help people with schizophrenia or schizoaffective disorder improve their social thinking and interactions. It may be a good option if you can use an app and are on stable medication.
Hear when a new First Episode Psychosis (FEP) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.